Zaproszenie do współpracy z ECS-Progastrin.

25 września 2019

We would like to kindly invite you to visit the booth #452 during the ESMO 2019 conference in Barcelona . We would be pleased to meet you there and share with you the latest information about our breakthrough Biomarker hPG80 (also named “Progastrin”).

This world-class breakthrough research innovation is based on the detection of circulating hPG80 in the blood of patients with cancers from various origins even at early stages.

ECS-Progastrin is a Swiss company which is making available this revolutionary new IVD test to enable more decision-making elements to physicians. This tool will be an aid in monitoring relapses and treatment follow-up of cancer patients.

ECS-progastrin has launched the last 3 years, a large collaboration plan with major cancer institutions across the world including Mayo Clinic (Rochester, USA) , Institute Curie (Paris, France), Hospice Civil de Lyon (France), Montpellier hospital (France) with which we had published results at the ESMO, AACR and ASCO annual meetings and new ones are coming.

We hope that after meeting us at our booth we could start strong collaboration as well.

If you would like to schedule an appointment with one of our main scientists during the course of the meeting:

Dominique Joubert PhD, the Pioneer of this Project,

Alexandre Prieur PhD, Chief Scientific Officer and

Thierry Cousin MD, Chief Medical Officer

please contact by phone : + 48 502 188 021 or by mail

At the same time, I would be very grateful for your help in dissemination of this information.